GENE ONLINE|News &
Reckitt Cuts Research Timelines by 65% Using AI Insights from NIQ
Reckitt has reportedly achieved significant advancements in its research processes by leveraging artificial intelligence (AI) insights provided by NIQ. According to recent reports, the company has managed to accelerate its research timelines by as much as 65%, marking a notable improvement in efficiency. This development highlights the growing role of AI-driven tools in streamlining innovation and decision-making within the consumer goods sector.
The collaboration between Reckitt and NIQ centers on utilizing advanced AI capabilities to analyze data more effectively and generate actionable insights at a faster pace. By integrating these tools into its operations, Reckitt has been able to reduce the time required for market research and product development processes. The company’s adoption of this technology underscores an industry-wide trend toward incorporating AI solutions to enhance productivity and maintain competitiveness in rapidly evolving markets.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 7, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Haloperidol Identified as Potential Treatment to Improve Muscle Function and Neuroprotection in Spinal Muscular Atrophy
2026-04-13
Advanced CRISPR System Using Al3Cas12f Enzyme Achieves 90 Percent Gene Editing Efficiency in Human Cells
2026-04-13
Researchers Map Pain-Sensing Neurons to Identify Proteins Linked to Chronic Inflammatory Pain
2026-04-13
FDA Grants Full Approval to Travere Therapeutics’ FILSPARI as First Medication for Treating FSGS
2026-04-13
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
